ENSG00000085224 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000085224 -0.4 5.24e-13 KIRC
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000085224 tumor 10766351
ENSG00000085224 cancer 11555636
ENSG00000085224 prostate tumors 16847812
ENSG00000085224 AML 16914901
ENSG00000085224 pancreatic neuroendocrine tumors 21252315
ENSG00000085224 tumors 21719641
ENSG00000085224 neuroendocrine tumors 22251937
ENSG00000085224 tumours 22286061
ENSG00000085224 tumour 22315652
ENSG00000085224 tumors 22416102
ENSG00000085224 pancreatic neuroendocrine tumors 22575867
ENSG00000085224 tumors 22661320
ENSG00000085224 tumours 22771539
ENSG00000085224 tumors 22829774
ENSG00000085224 tumors 22869205
ENSG00000085224 astrocytic tumors 22886134
ENSG00000085224 tumor 23104868
ENSG00000085224 tumors 23185534
ENSG00000085224 tumors 23202128
ENSG00000085224 tumor 23249563
ENSG00000085224 cancers 23284920
ENSG00000085224 pancreatic neuroendocrine tumors 23361940
ENSG00000085224 tumors 23391111
ENSG00000085224 astrocytic tumors 23417712
ENSG00000085224 tumors 23429284
ENSG00000085224 tumour 23429748
ENSG00000085224 cancer 23444137
ENSG00000085224 tumors 23530248
ENSG00000085224 cancer 23563309
ENSG00000085224 tumors 23583981
ENSG00000085224 tumor 23708087
ENSG00000085224 GBM 23760585
ENSG00000085224 tumors 23765250
ENSG00000085224 astrocytic tumors 23904111
ENSG00000085224 GBM 23906214
ENSG00000085224 tumor 23954140
ENSG00000085224 GBMs 24140581
ENSG00000085224 tumor 24147068
ENSG00000085224 pancreatic neuroendocrine tumors 24148618
ENSG00000085224 Tumors 24202337
ENSG00000085224 tumor 24336570
ENSG00000085224 tumors 24413054
ENSG00000085224 pancreatic neuroendocrine tumors 24436263
ENSG00000085224 GBMs 24445767
ENSG00000085224 tumors 24500201
ENSG00000085224 tumors 24559763
ENSG00000085224 cancer 24563217
ENSG00000085224 tumors 24622842
ENSG00000085224 tumours 24651726
ENSG00000085224 tumors 24703847
ENSG00000085224 tumors 24716189
ENSG00000085224 tumors 24792489
ENSG00000085224 tumors 24810474
ENSG00000085224 cancers 24834375
ENSG00000085224 GBM 24843883
ENSG00000085224 cancers 25045581
ENSG00000085224 tumor 25077701
ENSG00000085224 cancer 25092303
ENSG00000085224 tumors 25161957
ENSG00000085224 tumors 25182241
ENSG00000085224 pancreatic neuroendocrine tumors 25210493
ENSG00000085224 tumors 25227228
ENSG00000085224 tumors 25229770
ENSG00000085224 tumors 25257301
ENSG00000085224 GBM 25304031
ENSG00000085224 tumors 25427834
ENSG00000085224 tumor 25439321
ENSG00000085224 GBMs 25461780
ENSG00000085224 tumor 25467309
ENSG00000085224 GBMs 25479829
ENSG00000085224 tumor 25484917
ENSG00000085224 tumors 25487495
ENSG00000085224 cancers 25593184
ENSG00000085224 cancers 25608029
ENSG00000085224 tumor 25618849
ENSG00000085224 tumors 25639868
ENSG00000085224 GBMs 25646073
ENSG00000085224 oligodendroglial tumors 25664944
ENSG00000085224 tumors 25668564
ENSG00000085224 cancers 25690891
ENSG00000085224 tumor 25722939
ENSG00000085224 tumors 25743702
ENSG00000085224 tumors 25773741
ENSG00000085224 tumors 25785247
ENSG00000085224 cancer 25788983
ENSG00000085224 cancer 25803170
ENSG00000085224 GBM 25821160
ENSG00000085224 tumors 25853694
ENSG00000085224 cancers 25865896
ENSG00000085224 tumor 25943885
ENSG00000085224 astrocytic tumors 25971279
ENSG00000085224 breast cancers 25994018
ENSG00000085224 tumors 26001292
ENSG00000085224 GBMs 26004297
ENSG00000085224 Tumor 26014050
ENSG00000085224 tumours 26016385
ENSG00000085224 tumors 26022452
ENSG00000085224 tumors 26026117
ENSG00000085224 cancer 26055325
ENSG00000085224 cancer 26087898
ENSG00000085224 tumours 26143912
ENSG00000085224 malignant vascular tumors 26190196
ENSG00000085224 tumors 26210286
ENSG00000085224 tumors 26244119
ENSG00000085224 GBM 26253838
ENSG00000085224 malignant peripheral nerve sheath tumours 26291601
ENSG00000085224 cancers 26304540
ENSG00000085224 GBMs 26323991
ENSG00000085224 tumors 26355235
ENSG00000085224 tumors 26369702
ENSG00000085224 Cancer 26373274
ENSG00000085224 Cancer 26373281
ENSG00000085224 Tumors 26395639
ENSG00000085224 GBM 26427041
ENSG00000085224 tumors 26428317
ENSG00000085224 tumour 26466568
ENSG00000085224 tumors 26545048
ENSG00000085224 tumors 26556853
ENSG00000085224 tumours 26632267
ENSG00000085224 cancer 26646632
ENSG00000085224 tumor 26678657
ENSG00000085224 cancer 26692951
ENSG00000085224 cancer 26697514
ENSG00000085224 tumor 26699864
ENSG00000085224 tumour 26741321
ENSG00000085224 tumor 26753123
ENSG00000085224 cancers 26773061
ENSG00000085224 tumors 26794043
ENSG00000085224 Tumor 26817999
ENSG00000085224 GBMs 26833422
ENSG00000085224 tumors 26853339
ENSG00000085224 GBMs 26879021
ENSG00000085224 tumor 26891131
ENSG00000085224 tumor 26905832
ENSG00000085224 tumors 26910568
ENSG00000085224 tumors 26918938
ENSG00000085224 tumor 26936505
ENSG00000085224 tumors 27001774
ENSG00000085224 cancer 27009842
ENSG00000085224 cancers 27029610
ENSG00000085224 tumor 27036230
ENSG00000085224 tumors 27162024
ENSG00000085224 cancer 27171262
ENSG00000085224 tumor 27209355
ENSG00000085224 tumor 27267993
ENSG00000085224 tumors 27282637
ENSG00000085224 tumors 27311324
ENSG00000085224 cancer 27323951
ENSG00000085224 tumors 27342911
ENSG00000085224 Pancreatic Neuroendocrine Tumors 27407094
ENSG00000085224 tumors 27411289
ENSG00000085224 tumors 27418145
ENSG00000085224 astrocytic tumors 27425854
ENSG00000085224 tumors 27469217
ENSG00000085224 tumours 27499896
ENSG00000085224 oligodendroglial tumors 27556304
ENSG00000085224 cancer 27578458
ENSG00000085224 GBM 27579614
ENSG00000085224 tumors 27585244
ENSG00000085224 cancers 27590521
ENSG00000085224 tumors 27604789
ENSG00000085224 tumors 27657132
ENSG00000085224 pancreatic neuroendocrine tumors 27663587
ENSG00000085224 tumors 27698411
ENSG00000085224 astrocytic tumors 27713914
ENSG00000085224 tumors 27758882
ENSG00000085224 tumor 27788029
ENSG00000085224 oligodendroglial tumor 27796734
ENSG00000085224 tumors 27799281
ENSG00000085224 tumor 27852048
ENSG00000085224 cancers 27869828
ENSG00000085224 tumors 27994516
ENSG00000085224 tumors 27997549
ENSG00000085224 tumor 28030632
ENSG00000085224 tumors 28040793
ENSG00000085224 cancer 28042953
ENSG00000085224 tumors 28055978
ENSG00000085224 pediatric tumors 28062559
ENSG00000085224 tumor 28115389
ENSG00000085224 tumors 28135248
ENSG00000085224 cancers 28183782
ENSG00000085224 tumor 28210673
ENSG00000085224 tumor 28251430
ENSG00000085224 tumor 28255664
ENSG00000085224 tumours 28284043
ENSG00000085224 brain tumors 28303493
ENSG00000085224 brain tumors 28371217
ENSG00000085224 pancreatic neuroendocrine tumors 28371511
ENSG00000085224 CNS tumor 28392842
ENSG00000085224 cervical cancer 28395727
ENSG00000085224 tumors 28451993
ENSG00000085224 tumors 28452859
ENSG00000085224 tumors 28454119
ENSG00000085224 tumours 28484589
ENSG00000085224 tumours 28487353
ENSG00000085224 brain tumor 28488024
ENSG00000085224 GBM 28497778
ENSG00000085224 tumor 28513547
ENSG00000085224 tumor 28546523
ENSG00000085224 tumor 28591701
ENSG00000085224 tumor 28597868
ENSG00000085224 tumours 28654422
ENSG00000085224 tumor 28695151
ENSG00000085224 tumor 28696020
ENSG00000085224 tumor 28699883
ENSG00000085224 Cancer 28710315
ENSG00000085224 tumors 28718400
ENSG00000085224 Neuroendocrine Tumors 28719461
ENSG00000085224 cancers 28741530
ENSG00000085224 tumours 28796347
ENSG00000085224 tumors 28823044
ENSG00000085224 cancer 28851357
ENSG00000085224 GBMs 28851427
ENSG00000085224 cancer 28855512
ENSG00000085224 tumor 28877067
ENSG00000085224 cancer 28883432
ENSG00000085224 tumours 28955830
ENSG00000085224 GBMs 28958143
ENSG00000085224 GBM 28966033
ENSG00000085224 tumors 28979716
ENSG00000085224 tumor 28993028
ENSG00000085224 Tumours 29026176
ENSG00000085224 tumors 29027701
ENSG00000085224 tumors 29034211
ENSG00000085224 astrocytic tumors 29050070
ENSG00000085224 tumours 29053887
ENSG00000085224 tumors 29084603
ENSG00000085224 Tumors 29084956
ENSG00000085224 tumours 29098416
ENSG00000085224 tumour 29099032
ENSG00000085224 tumors 29107533
ENSG00000085224 neuroendocrine tumors 29144820
ENSG00000085224 tumors 29156578
ENSG00000085224 tumors 29163774
ENSG00000085224 AML 29196926
ENSG00000085224 tumor 29212165
ENSG00000085224 tumours 29258767
ENSG00000085224 high-grade astrocytic tumor 29264735
ENSG00000085224 GBMs 29302887
ENSG00000085224 tumor 29312603
ENSG00000085224 tumours 29321190
ENSG00000085224 tumors 29321523
ENSG00000085224 GBM 29359122
ENSG00000085224 tumors 29403544
ENSG00000085224 tumours 29444910
ENSG00000085224 cancers 29463031
ENSG00000085224 cancer 29479426
ENSG00000085224 tumors 29486199
ENSG00000085224 GBM 29509313
ENSG00000085224 GBM 29521646
ENSG00000085224 tumors 29521944
ENSG00000085224 astrocytic tumors 29527387
ENSG00000085224 tumors 29535300
ENSG00000085224 Cancer 29545335
ENSG00000085224 GBM 29548052
ENSG00000085224 cancer 29550762
ENSG00000085224 tumors 29550880
ENSG00000085224 tumor 29560102
ENSG00000085224 tumor 29596894
ENSG00000085224 tumors 29600313
ENSG00000085224 tumors 29602769
ENSG00000085224 tumor 29615461
ENSG00000085224 tumor 29616301
ENSG00000085224 tumors 29631562
ENSG00000085224 tumors 29660202
ENSG00000085224 cancers 29669917
ENSG00000085224 cancer 29706636
ENSG00000085224 tumours 29718321
ENSG00000085224 tumours 29720725
ENSG00000085224 tumours 29721688
ENSG00000085224 Tumors 29727696
ENSG00000085224 tumours 29751586
ENSG00000085224 tumours 29755120
ENSG00000085224 tumor 29763623
ENSG00000085224 tumor 29776332
ENSG00000085224 tumor 29796169
ENSG00000085224 tumors 29802247
ENSG00000085224 tumors 29805974
ENSG00000085224 tumor 29846902
ENSG00000085224 cancer 29889582
ENSG00000085224 GBMs 29896287
ENSG00000085224 tumors 29937341
ENSG00000085224 cancer 29973652
ENSG00000085224 cancer 29992434
ENSG00000085224 tumor 30006355
ENSG00000085224 GBMs 30010995
ENSG00000085224 GBMs 30038102
ENSG00000085224 tumor 30062048
ENSG00000085224 cancer 30073207
ENSG00000085224 tumors 30073524
ENSG00000085224 pancreatic neuroendocrine tumors 30081149
ENSG00000085224 cancers 30087349
ENSG00000085224 Tumor 30107580
ENSG00000085224 tumor 30192422
ENSG00000085224 tumor 30214228
ENSG00000085224 cancers 30214690
ENSG00000085224 Cancers 30226859
ENSG00000085224 tumors 30234181
ENSG00000085224 tumors 30263090
ENSG00000085224 tumor 30263940
ENSG00000085224 tumors 30279357
ENSG00000085224 tumors 30301828
ENSG00000085224 gallbladder cancer 30304546
ENSG00000085224 pancreatic neuroendocrine tumors 30315258
ENSG00000085224 GBMs 30333046
ENSG00000085224 cancer 30341300
ENSG00000085224 tumor 30400878
ENSG00000085224 colon cancer 30405805
ENSG00000085224 cancer 30465651
ENSG00000085224 GBMs 30504574
ENSG00000085224 cancers 30510993
ENSG00000085224 tumors 30531922
ENSG00000085224 tumor 30538672
ENSG00000085224 brain tumors 30539453
ENSG00000085224 tumour 30565681
ENSG00000085224 pancreatic neuroendocrine tumors 30590707
ENSG00000085224 glial tumor 30592195
ENSG00000085224 tumor 30598078
ENSG00000085224 tumor 30611004
ENSG00000085224 Tumor 30625996
ENSG00000085224 tumors 30627226
ENSG00000085224 tumors 30654820
ENSG00000085224 tumors 30655743
ENSG00000085224 tumor 30657883
ENSG00000085224 tumors 30658672
ENSG00000085224 tumors 30738431
ENSG00000085224 cancer 30745338
ENSG00000085224 cancer 30755392
ENSG00000085224 tumors 30760578
ENSG00000085224 tumors 30760980
ENSG00000085224 tumours 30786920
ENSG00000085224 cancers 30808951
ENSG00000085224 tumors 30831644
ENSG00000085224 tumor 30833786
ENSG00000085224 cancer 30872255
ENSG00000085224 tumors 30872698
ENSG00000085224 cancer 30889380
ENSG00000085224 GBMs 30936423
ENSG00000085224 tumors 30937985
ENSG00000085224 tumours 30946477
ENSG00000085224 tumor 30957015
ENSG00000085224 tumor 30967140
ENSG00000085224 tumor 30970016
ENSG00000085224 tumor 31018240
ENSG00000085224 tumour 31018710
ENSG00000085224 cancers 31062529
ENSG00000085224 cancer 31086817
ENSG00000085224 tumors 31115468
ENSG00000085224 tumor 31124566
ENSG00000085224 tumors 31128432
ENSG00000085224 GBM 31152217
ENSG00000085224 tumor 31160355
ENSG00000085224 tumors 31200515
ENSG00000085224 tumor 31212687
ENSG00000085224 Pineal Parenchymal Tumors of Intermediate Differentiation 31225581
ENSG00000085224 tumor 31248429
ENSG00000085224 tumor 31290679
ENSG00000085224 tumors 31290759
ENSG00000085224 tumor 31311166
ENSG00000085224 cancer 31329278
ENSG00000085224 cancer 31336873
ENSG00000085224 cancer 31341965
ENSG00000085224 Cancer 31371348
ENSG00000085224 lung cancer 31374064
ENSG00000085224 tumors 31435515
ENSG00000085224 tumour 31443481
ENSG00000085224 tumor 31447390
ENSG00000085224 cancers 31454099
ENSG00000085224 tumors 31462295
ENSG00000085224 pulmonary carcinoid tumors 31499081
ENSG00000085224 cancer 31500094
ENSG00000085224 GBMs 31505839
ENSG00000085224 tumor 31520766
ENSG00000085224 cancers 31546714
ENSG00000085224 Cancers 31551363
ENSG00000085224 tumours 31555489
ENSG00000085224 Pancreatic Neuroendocrine Tumors 31599805
ENSG00000085224 tumor 31604779
ENSG00000085224 Prostate Cancer 31611308
ENSG00000085224 tumors 31647501
ENSG00000085224 tumors 31647544
ENSG00000085224 tumors 31661039
ENSG00000085224 tumors 31692857
ENSG00000085224 tumors 31706351
ENSG00000085224 cancers 31750255
ENSG00000085224 tumor 31771970
ENSG00000085224 tumor 31811342
ENSG00000085224 nonfunctioning tumors 31819132
ENSG00000085224 Cancer 31908895
ENSG00000085224 GBM 31930277
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000085224 brain glioblastoma frameshift_variant 8.355% (130/1556) 10 entries
ENSG00000085224 pancreatic neuroendocrine tumor missense_variant 13.44% (41/305) 3 entries
ENSG00000085224 brain astrocytoma stop_gained 43.75% (21/48) 1 entry
ENSG00000085224 brain glioblastoma sequence_alteration 8.355% (130/1556) 5 entries
ENSG00000085224 oligoastrocytoma sequence_alteration 48.21% (27/56) 3 entries
ENSG00000085224 colon adenocarcinoma stop_gained 8.34% (108/1295) 2 entries
ENSG00000085224 cecum adenocarcinoma sequence_alteration 11.11% (30/270) 1 entry
ENSG00000085224 leiomyosarcoma frameshift_variant 23.33% (28/120) 3 entries
ENSG00000085224 colon adenocarcinoma sequence_alteration 8.34% (108/1295) 3 entries
ENSG00000085224 anaplastic oligoastrocytoma missense_variant 46.99% (39/83) 4 entries
ENSG00000085224 oligoastrocytoma stop_gained 48.21% (27/56) 3 entries
ENSG00000085224 pancreatic neuroendocrine tumor frameshift_variant 13.44% (41/305) 3 entries
ENSG00000085224 colon adenocarcinoma frameshift_variant 8.34% (108/1295) 5 entries
ENSG00000085224 pancreatic neuroendocrine tumor stop_gained 13.44% (41/305) 3 entries
ENSG00000085224 oligoastrocytoma missense_variant 48.21% (27/56) 2 entries
ENSG00000085224 glioma missense_variant 12.2% (85/697) 1 entry
ENSG00000085224 glioma frameshift_variant 12.2% (85/697) 2 entries
ENSG00000085224 glioma stop_gained 12.2% (85/697) 2 entries
ENSG00000085224 breast ductal adenocarcinoma missense_variant 9.948% (171/1719) 2 entries
ENSG00000085224 anaplastic astrocytoma sequence_alteration 49.34% (112/227) 3 entries
ENSG00000085224 breast ductal adenocarcinoma stop_gained 9.948% (171/1719) 2 entries
ENSG00000085224 brain glioblastoma missense_variant 8.355% (130/1556) 7 entries
ENSG00000085224 anaplastic oligoastrocytoma stop_gained 46.99% (39/83) 4 entries
ENSG00000085224 anaplastic astrocytoma frameshift_variant 49.34% (112/227) 7 entries
ENSG00000085224 brain astrocytoma frameshift_variant 43.75% (21/48) 1 entry
ENSG00000085224 cecum adenocarcinoma missense_variant 11.11% (30/270) 3 entries
ENSG00000085224 HER2 Positive Breast Carcinoma missense_variant 26.09% (36/138) 1 entry
ENSG00000085224 breast ductal adenocarcinoma sequence_alteration 9.948% (171/1719) 3 entries
ENSG00000085224 oligoastrocytoma frameshift_variant 48.21% (27/56) 6 entries
ENSG00000085224 pancreatic neuroendocrine tumor sequence_alteration 13.44% (41/305) 1 entry
ENSG00000085224 brain glioblastoma stop_gained 8.355% (130/1556) 7 entries
ENSG00000085224 cecum adenocarcinoma frameshift_variant 11.11% (30/270) 3 entries
ENSG00000085224 leiomyosarcoma missense_variant 23.33% (28/120) 1 entry
ENSG00000085224 HER2 Positive Breast Carcinoma sequence_alteration 26.09% (36/138) 1 entry
ENSG00000085224 anaplastic oligoastrocytoma sequence_alteration 46.99% (39/83) 3 entries
ENSG00000085224 glioma sequence_alteration 12.2% (85/697) 1 entry
ENSG00000085224 leiomyosarcoma stop_gained 23.33% (28/120) 2 entries
ENSG00000085224 colon adenocarcinoma missense_variant 8.34% (108/1295) 11 entries
ENSG00000085224 colon adenocarcinoma conservative_inframe_deletion 8.34% (108/1295) 2 entries
ENSG00000085224 anaplastic oligoastrocytoma frameshift_variant 46.99% (39/83) 6 entries
ENSG00000085224 leiomyosarcoma sequence_alteration 23.33% (28/120) 1 entry
ENSG00000085224 brain astrocytoma sequence_alteration 43.75% (21/48) 1 entry
ENSG00000085224 anaplastic astrocytoma missense_variant 49.34% (112/227) 5 entries
ENSG00000085224 anaplastic astrocytoma stop_gained 49.34% (112/227) 8 entries
ENSG00000085224 acute myeloid leukemia stop_gained 0.8624% (24/2783) 1 entry
ENSG00000085224 undifferentiated pleomorphic sarcoma stop_gained 14.52% (9/62) 1 entry
ENSG00000085224 glioma amino_acid_insertion 12.2% (85/697) 1 entry
ENSG00000085224 clear cell renal carcinoma missense_variant 1.3% (21/1616) 4 entries
ENSG00000085224 Uterine Carcinosarcoma sequence_alteration 8.485% (14/165) 1 entry
ENSG00000085224 Cortisol-Producing Adrenal Cortex Adenoma missense_variant 1.613% (2/124) 2 entries
ENSG00000085224 skin melanoma stop_gained 4.217% (49/1162) 3 entries
ENSG00000085224 papillary renal cell carcinoma missense_variant 0.5155% (2/388) 1 entry
ENSG00000085224 lung adenocarcinoma sequence_alteration 4.551% (117/2571) 3 entries
ENSG00000085224 Uterine Carcinosarcoma missense_variant 8.485% (14/165) 2 entries
ENSG00000085224 adrenal gland pheochromocytoma missense_variant 3.136% (9/287) 2 entries
ENSG00000085224 Endometrial Endometrioid Adenocarcinoma missense_variant 4.923% (32/650) 2 entries
ENSG00000085224 breast carcinoma frameshift_variant 2.091% (35/1674) 2 entries
ENSG00000085224 Adrenal Gland Neuroblastoma missense_variant 6.818% (6/88) 1 entry
ENSG00000085224 pancreatic neuroendocrine tumor conservative_inframe_deletion 13.44% (41/305) 1 entry
ENSG00000085224 female breast carcinoma missense_variant 3.767% (11/292) 4 entries
ENSG00000085224 hemangioblastoma missense_variant 22.86% (8/35) 1 entry
ENSG00000085224 breast carcinoma conservative_inframe_deletion 2.091% (35/1674) 1 entry
ENSG00000085224 lung adenocarcinoma frameshift_variant 4.551% (117/2571) 3 entries
ENSG00000085224 hepatocellular carcinoma missense_variant 1.763% (18/1021) 2 entries
ENSG00000085224 colorectal adenocarcinoma frameshift_variant 6.924% (88/1271) 2 entries
ENSG00000085224 papillary thyroid carcinoma missense_variant 1.174% (6/511) 2 entries
ENSG00000085224 breast carcinoma missense_variant 2.091% (35/1674) 3 entries
ENSG00000085224 Adrenal Gland Neuroblastoma frameshift_variant 6.818% (6/88) 1 entry
ENSG00000085224 lung adenocarcinoma stop_gained 4.551% (117/2571) 4 entries
ENSG00000085224 Gallbladder Adenocarcinoma sequence_alteration 5.455% (9/165) 1 entry
ENSG00000085224 Merkel cell skin cancer missense_variant 4.211% (4/95) 2 entries
ENSG00000085224 small cell lung carcinoma sequence_alteration 6.321% (28/443) 2 entries
ENSG00000085224 adrenal cortex carcinoma stop_gained 3.67% (8/218) 2 entries
ENSG00000085224 basal cell carcinoma missense_variant 14.71% (10/68) 2 entries
ENSG00000085224 astrocytoma missense_variant 40.0% (6/15) 2 entries
ENSG00000085224 skin melanoma missense_variant 4.217% (49/1162) 5 entries
ENSG00000085224 small cell lung carcinoma missense_variant 6.321% (28/443) 5 entries
ENSG00000085224 melanoma missense_variant 13.01% (19/146) 3 entries
ENSG00000085224 Cervical Small Cell Carcinoma missense_variant 50.0% (4/8) 1 entry
ENSG00000085224 clear cell renal carcinoma sequence_alteration 1.3% (21/1616) 1 entry
ENSG00000085224 mucosal melanoma frameshift_variant 15.71% (11/70) 1 entry
ENSG00000085224 large cell lung carcinoma missense_variant 10.53% (2/19) 1 entry
ENSG00000085224 nasopharyngeal squamous cell carcinoma frameshift_variant 3.247% (10/308) 1 entry
ENSG00000085224 colorectal adenocarcinoma missense_variant 6.924% (88/1271) 4 entries
ENSG00000085224 brain astrocytoma missense_variant 43.75% (21/48) 1 entry
ENSG00000085224 esophageal adenocarcinoma missense_variant 1.825% (10/548) 2 entries
ENSG00000085224 colon adenocarcinoma amino_acid_insertion 8.34% (108/1295) 1 entry
ENSG00000085224 undifferentiated pleomorphic sarcoma frameshift_variant 14.52% (9/62) 1 entry
ENSG00000085224 urothelial carcinoma missense_variant 9.302% (8/86) 1 entry
ENSG00000085224 neoplasm missense_variant 7.895% (3/38) 1 entry
ENSG00000085224 osteosarcoma stop_gained 6.369% (10/157) 3 entries
ENSG00000085224 cecum adenocarcinoma conservative_inframe_deletion 11.11% (30/270) 1 entry
ENSG00000085224 pleomorphic liposarcoma frameshift_variant 44.44% (4/9) 2 entries
ENSG00000085224 non-small cell lung carcinoma missense_variant 5.556% (6/108) 2 entries
ENSG00000085224 small cell lung carcinoma stop_gained 6.321% (28/443) 3 entries
ENSG00000085224 chronic lymphocytic leukemia missense_variant 4.372% (39/892) 1 entry
ENSG00000085224 brain glioblastoma amino_acid_insertion 8.355% (130/1556) 1 entry
ENSG00000085224 Gallbladder Adenocarcinoma missense_variant 5.455% (9/165) 3 entries
ENSG00000085224 bladder transitional cell carcinoma missense_variant 3.68% (17/462) 2 entries
ENSG00000085224 squamous cell lung carcinoma sequence_alteration 2.146% (20/932) 1 entry
ENSG00000085224 bladder transitional cell carcinoma frameshift_variant 3.68% (17/462) 1 entry
ENSG00000085224 Brain Stem Glioblastoma missense_variant 8.571% (6/70) 2 entries
ENSG00000085224 gastric adenocarcinoma missense_variant 2.973% (25/841) 5 entries
ENSG00000085224 pancreatic ductal adenocarcinoma missense_variant 6.306% (113/1792) 3 entries
ENSG00000085224 lobular breast carcinoma missense_variant 5.435% (15/276) 2 entries
ENSG00000085224 myelodysplastic syndrome sequence_alteration 3.515% (29/825) 4 entries
ENSG00000085224 prostate adenocarcinoma conservative_inframe_deletion 3.614% (78/2158) 1 entry
ENSG00000085224 ulcerative colitis stop_gained 44.44% (4/9) 1 entry
ENSG00000085224 oral squamous cell carcinoma missense_variant 2.29% (6/262) 4 entries
ENSG00000085224 mucosal melanoma stop_gained 15.71% (11/70) 1 entry
ENSG00000085224 basal cell carcinoma stop_gained 14.71% (10/68) 1 entry
ENSG00000085224 Myelodysplastic/Myeloproliferative Neoplasm missense_variant 20.0% (3/15) 2 entries
ENSG00000085224 prostate adenocarcinoma sequence_alteration 3.614% (78/2158) 1 entry
ENSG00000085224 prostate carcinoma missense_variant 1.549% (7/452) 3 entries
ENSG00000085224 Brain Stem Glioblastoma sequence_alteration 8.571% (6/70) 2 entries
ENSG00000085224 nasopharyngeal squamous cell carcinoma missense_variant 3.247% (10/308) 3 entries
ENSG00000085224 rectal adenocarcinoma frameshift_variant 2.559% (14/547) 1 entry
ENSG00000085224 ovarian serous adenocarcinoma missense_variant 0.949% (8/843) 4 entries
ENSG00000085224 colorectal adenocarcinoma conservative_inframe_deletion 6.924% (88/1271) 2 entries
ENSG00000085224 brain glioma missense_variant 13.95% (6/43) 2 entries
ENSG00000085224 prostate adenocarcinoma missense_variant 3.614% (78/2158) 3 entries
ENSG00000085224 myelodysplastic syndrome stop_gained 3.515% (29/825) 2 entries
ENSG00000085224 Endometrial Endometrioid Adenocarcinoma stop_gained 4.923% (32/650) 2 entries
ENSG00000085224 mucosal melanoma amino_acid_insertion 15.71% (11/70) 1 entry
ENSG00000085224 acute myeloid leukemia missense_variant 0.8624% (24/2783) 3 entries
ENSG00000085224 brain astrocytoma conservative_inframe_deletion 43.75% (21/48) 1 entry
ENSG00000085224 rectal adenocarcinoma missense_variant 2.559% (14/547) 3 entries
ENSG00000085224 osteosarcoma missense_variant 6.369% (10/157) 2 entries
ENSG00000085224 Kidney Angiomyolipoma frameshift_variant 25.0% (2/8) 1 entry
ENSG00000085224 rectal adenocarcinoma stop_gained 2.559% (14/547) 1 entry
ENSG00000085224 myelodysplastic syndrome missense_variant 3.515% (29/825) 5 entries
ENSG00000085224 adrenal gland pheochromocytoma conservative_inframe_deletion 3.136% (9/287) 1 entry
ENSG00000085224 gastric intestinal type adenocarcinoma missense_variant 3.529% (3/85) 2 entries
ENSG00000085224 melanoma conservative_inframe_deletion 13.01% (19/146) 1 entry
ENSG00000085224 squamous cell lung carcinoma missense_variant 2.146% (20/932) 1 entry
ENSG00000085224 esophageal squamous cell carcinoma missense_variant 1.887% (13/689) 4 entries
ENSG00000085224 diffuse large B-cell lymphoma missense_variant 0.7143% (3/420) 2 entries
ENSG00000085224 osteosarcoma frameshift_variant 6.369% (10/157) 2 entries
ENSG00000085224 Non-Functional Pancreatic Neuroendocrine Tumor missense_variant 22.58% (7/31) 1 entry
ENSG00000085224 esophageal squamous cell carcinoma stop_gained 1.887% (13/689) 1 entry
ENSG00000085224 anaplastic oligodendroglioma missense_variant 3.974% (6/151) 2 entries
ENSG00000085224 colorectal adenocarcinoma stop_gained 6.924% (88/1271) 2 entries
ENSG00000085224 hemangioblastoma sequence_alteration 22.86% (8/35) 1 entry
ENSG00000085224 bladder carcinoma missense_variant 3.922% (22/561) 1 entry
ENSG00000085224 breast carcinoma stop_gained 2.091% (35/1674) 2 entries
ENSG00000085224 central nervous system primitive neuroectodermal neoplasm frameshift_variant 3.602% (21/583) 2 entries
ENSG00000085224 oligoastrocytoma translational_product_function_variant 48.21% (27/56) 1 entry
ENSG00000085224 astrocytoma stop_gained 40.0% (6/15) 1 entry
ENSG00000085224 female breast carcinoma sequence_alteration 3.767% (11/292) 1 entry
ENSG00000085224 breast ductal adenocarcinoma conservative_inframe_deletion 9.948% (171/1719) 1 entry
ENSG00000085224 anaplastic oligodendroglioma frameshift_variant 3.974% (6/151) 2 entries
ENSG00000085224 prostate adenocarcinoma frameshift_variant 3.614% (78/2158) 2 entries
ENSG00000085224 squamous cell lung carcinoma stop_gained 2.146% (20/932) 1 entry
ENSG00000085224 diffuse large B-cell lymphoma sequence_alteration 0.7143% (3/420) 1 entry
ENSG00000085224 lung adenocarcinoma missense_variant 4.551% (117/2571) 9 entries
ENSG00000085224 myelodysplastic syndrome frameshift_variant 3.515% (29/825) 2 entries
ENSG00000085224 colorectal adenocarcinoma sequence_alteration 6.924% (88/1271) 2 entries
ENSG00000085224 chronic myelomonocytic leukemia missense_variant 1.778% (4/225) 2 entries
ENSG00000085224 Hepatoblastoma sequence_alteration 13.33% (2/15) 1 entry
ENSG00000085224 acute lymphoblastic leukemia missense_variant 0.6231% (2/321) 2 entries
ENSG00000085224 Breast Carcinoma by Gene Expression Profile missense_variant 4.167% (4/96) 1 entry
ENSG00000085224 Non-Functional Pancreatic Neuroendocrine Tumor frameshift_variant 22.58% (7/31) 1 entry
ENSG00000085224 PEComa frameshift_variant 13.33% (2/15) 1 entry
ENSG00000085224 Adrenal Gland Neuroblastoma stop_gained 6.818% (6/88) 1 entry
ENSG00000085224 Pineocytoma sequence_alteration 33.33% (1/3) 1 entry
ENSG00000085224 diffuse gastric adenocarcinoma missense_variant 1.22% (1/82) 1 entry
ENSG00000085224 Pancreatic Acinar Cell Carcinoma missense_variant 2.941% (1/34) 1 entry
ENSG00000085224 Non-Functional Pancreatic Neuroendocrine Tumor stop_gained 22.58% (7/31) 1 entry
ENSG00000085224 kidney Wilms tumor sequence_alteration 0.303% (1/330) 1 entry
ENSG00000085224 Thymic Small Cell Carcinoma missense_variant 100.0% (1/1) 1 entry
ENSG00000085224 laryngeal squamous cell carcinoma missense_variant 2.439% (1/41) 1 entry
ENSG00000085224 urothelial carcinoma stop_gained 9.302% (8/86) 1 entry
ENSG00000085224 soft tissue sarcoma missense_variant 1.02% (3/294) 1 entry
ENSG00000085224 urothelial carcinoma frameshift_variant 9.302% (8/86) 1 entry
ENSG00000085224 astrocytoma sequence_alteration 40.0% (6/15) 1 entry
ENSG00000085224 chondrosarcoma frameshift_variant 7.692% (1/13) 1 entry
ENSG00000085224 PEComa stop_gained 13.33% (2/15) 1 entry
ENSG00000085224 Ampulla of Vater Carcinoma frameshift_variant 1.176% (1/85) 1 entry
ENSG00000085224 Peritoneal Well Differentiated Papillary Mesothelioma missense_variant 10.0% (1/10) 1 entry
ENSG00000085224 bronchoalveolar adenocarcinoma missense_variant 4.545% (1/22) 1 entry
ENSG00000085224 mixed neuronal-glial tumor stop_gained 11.11% (1/9) 1 entry
ENSG00000085224 prostate adenocarcinoma stop_gained 3.614% (78/2158) 1 entry
ENSG00000085224 salivary gland carcinoma frameshift_variant 3.03% (1/33) 1 entry
ENSG00000085224 nasal cavity and paranasal sinus carcinoma missense_variant 8.696% (2/23) 1 entry
ENSG00000085224 pleomorphic liposarcoma stop_gained 44.44% (4/9) 1 entry
ENSG00000085224 Ovarian Small Cell Carcinoma sequence_alteration 6.667% (1/15) 1 entry
ENSG00000085224 Cervical Clear Cell Adenocarcinoma stop_gained 100.0% (1/1) 1 entry
ENSG00000085224 Mantle cell lymphoma missense_variant 1.493% (1/67) 1 entry
ENSG00000085224 Gastric Neuroendocrine Tumor G1 frameshift_variant 9.091% (1/11) 1 entry
ENSG00000085224 papillary thyroid carcinoma frameshift_variant 1.174% (6/511) 1 entry
ENSG00000085224 angiosarcoma stop_gained 4.167% (2/48) 1 entry
ENSG00000085224 astrocytoma conservative_inframe_deletion 40.0% (6/15) 1 entry
ENSG00000085224 Dysplasia in Ulcerative Colitis stop_gained 12.5% (1/8) 1 entry
ENSG00000085224 mucosal melanoma missense_variant 15.71% (11/70) 1 entry
ENSG00000085224 head and neck squamous cell carcinoma missense_variant 0.4005% (3/749) 1 entry
ENSG00000085224 colon carcinoma conservative_inframe_deletion 12.5% (1/8) 1 entry
ENSG00000085224 Vaginal Squamous Cell Carcinoma missense_variant 50.0% (1/2) 1 entry
ENSG00000085224 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma missense_variant 0.7576% (2/264) 1 entry
ENSG00000085224 undifferentiated pleomorphic sarcoma sequence_alteration 14.52% (9/62) 1 entry
ENSG00000085224 Non-Functional Pancreatic Neuroendocrine Tumor sequence_alteration 22.58% (7/31) 1 entry
ENSG00000085224 ovarian clear cell adenocarcinoma missense_variant 3.03% (1/33) 1 entry
ENSG00000085224 Mediastinal Neuroblastoma missense_variant 20.0% (1/5) 1 entry
ENSG00000085224 female breast carcinoma frameshift_variant 3.767% (11/292) 1 entry
ENSG00000085224 ulcerative colitis missense_variant 44.44% (4/9) 1 entry
ENSG00000085224 lobular breast carcinoma stop_gained 5.435% (15/276) 1 entry
ENSG00000085224 neoplasm of mature B-cells missense_variant 1.538% (1/65) 1 entry
ENSG00000085224 undifferentiated pleomorphic sarcoma conservative_inframe_deletion 14.52% (9/62) 1 entry
ENSG00000085224 brain glioma frameshift_variant 13.95% (6/43) 1 entry
ENSG00000085224 mesenchymal chondrosarcoma stop_gained 33.33% (1/3) 1 entry
ENSG00000085224 nasal cavity and paranasal sinus carcinoma stop_gained 8.696% (2/23) 1 entry
ENSG00000085224 undifferentiated pleomorphic sarcoma missense_variant 14.52% (9/62) 1 entry
ENSG00000085224 oligodendroglioma stop_gained 25.0% (1/4) 1 entry
ENSG00000085224 Adrenal Gland Neuroblastoma sequence_alteration 6.818% (6/88) 1 entry
ENSG00000085224 Anal Squamous Cell Carcinoma missense_variant 1.205% (1/83) 1 entry
ENSG00000085224 rhabdomyosarcoma sequence_alteration 2.778% (1/36) 1 entry
ENSG00000085224 Parotid Gland Adenoid Cystic Carcinoma missense_variant 7.692% (1/13) 1 entry
ENSG00000085224 choroid plexus carcinoma missense_variant 20.0% (1/5) 1 entry
ENSG00000085224 Gastrointestinal stromal tumor missense_variant 0.6579% (1/152) 1 entry
ENSG00000085224 head and neck squamous cell carcinoma conservative_inframe_deletion 0.4005% (3/749) 1 entry
ENSG00000085224 adrenal gland pheochromocytoma frameshift_variant 3.136% (9/287) 1 entry
ENSG00000085224 bone osteosarcoma missense_variant 33.33% (1/3) 1 entry
ENSG00000085224 chromophobe renal cell carcinoma missense_variant 0.6757% (1/148) 1 entry
ENSG00000085224 extra-adrenal sympathetic paraganglioma stop_gained 50.0% (1/2) 1 entry
ENSG00000085224 Benign Adrenal Gland Pheochromocytoma frameshift_variant 3.636% (2/55) 1 entry
ENSG00000085224 skin melanoma sequence_alteration 4.217% (49/1162) 1 entry
ENSG00000085224 basal cell carcinoma sequence_alteration 14.71% (10/68) 1 entry
ENSG00000085224 Spinal Cord Astrocytoma stop_gained 25.0% (1/4) 1 entry
ENSG00000085224 Duodenal Adenocarcinoma missense_variant 5.882% (1/17) 1 entry
ENSG00000085224 B-cell acute lymphoblastic leukemia stop_gained 0.8929% (1/112) 1 entry
ENSG00000085224 Bladder Adenocarcinoma frameshift_variant 14.29% (1/7) 1 entry
ENSG00000085224 soft tissue sarcoma frameshift_variant 1.02% (3/294) 1 entry
ENSG00000085224 Merkel cell skin cancer sequence_alteration 4.211% (4/95) 1 entry
ENSG00000085224 gastric adenocarcinoma frameshift_variant 2.973% (25/841) 1 entry
ENSG00000085224 Conjunctival Melanoma stop_gained 25.0% (1/4) 1 entry
ENSG00000085224 Vulvar Squamous Cell Carcinoma stop_gained 5.263% (1/19) 1 entry
ENSG00000085224 skin melanoma frameshift_variant 4.217% (49/1162) 1 entry
ENSG00000085224 follicular thyroid carcinoma missense_variant 1.429% (1/70) 1 entry
ENSG00000085224 angiosarcoma frameshift_variant 4.167% (2/48) 1 entry
ENSG00000085224 adrenal cortex carcinoma conservative_inframe_deletion 3.67% (8/218) 1 entry
ENSG00000085224 hepatocellular carcinoma frameshift_variant 1.763% (18/1021) 1 entry
ENSG00000085224 renal carcinoma missense_variant 5.0% (1/20) 1 entry
ENSG00000085224 head and neck squamous cell carcinoma sequence_alteration 0.4005% (3/749) 1 entry
ENSG00000085224 renal cell carcinoma missense_variant 1.471% (1/68) 1 entry
ENSG00000085224 ovarian serous adenocarcinoma stop_gained 0.949% (8/843) 1 entry
ENSG00000085224 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma sequence_alteration 0.7576% (2/264) 1 entry
ENSG00000085224 Benign Adrenal Gland Pheochromocytoma sequence_alteration 3.636% (2/55) 1 entry
ENSG00000085224 mucosal melanoma sequence_alteration 15.71% (11/70) 1 entry
ENSG00000085224 osteosarcoma sequence_alteration 6.369% (10/157) 1 entry
ENSG00000085224 adrenal cortex carcinoma missense_variant 3.67% (8/218) 1 entry
ENSG00000085224 adrenal cortex carcinoma frameshift_variant 3.67% (8/218) 1 entry
ENSG00000085224 lung PEComa stop_gained 100.0% (1/1) 1 entry
ENSG00000085224 ovarian serous adenocarcinoma frameshift_variant 0.949% (8/843) 1 entry
ENSG00000085224 melanoma stop_gained 13.01% (19/146) 1 entry
ENSG00000085224 Brain Stem Glioblastoma frameshift_variant 8.571% (6/70) 1 entry
ENSG00000085224 oral squamous cell carcinoma sequence_alteration 2.29% (6/262) 1 entry
ENSG00000085224 Cervical Small Cell Carcinoma stop_gained 50.0% (4/8) 1 entry
ENSG00000085224 Appendix Adenocarcinoma missense_variant 1.351% (1/74) 1 entry
ENSG00000085224 anaplastic oligodendroglioma sequence_alteration 3.974% (6/151) 1 entry
ENSG00000085224 soft tissue sarcoma stop_gained 1.02% (3/294) 1 entry
ENSG00000085224 melanoma sequence_alteration 13.01% (19/146) 1 entry
ENSG00000085224 adrenocortical adenoma stop_gained 2.439% (1/41) 1 entry
ENSG00000085224 pleomorphic liposarcoma missense_variant 44.44% (4/9) 1 entry
ENSG00000085224 primary peritoneal carcinoma (disease) frameshift_variant 100.0% (1/1) 1 entry
ENSG00000085224 meningioma (disease) missense_variant 1.37% (1/73) 1 entry
ENSG00000085224 adrenal cortex carcinoma sequence_alteration 3.67% (8/218) 1 entry
ENSG00000085224 pharyngeal squamous cell carcinoma missense_variant 0.6993% (1/143) 1 entry
ENSG00000085224 rectal adenocarcinoma sequence_alteration 2.559% (14/547) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000085224 MESO 0.012 low
ENSG00000085224 UCEC 0.026 high
ENSG00000085224 THCA 0.017 high
ENSG00000085224 ACC 0.037 low
ENSG00000085224 LGG 0.0055 high
ENSG00000085224 LUSC 0.018 low
ENSG00000085224 READ 0.023 low
ENSG00000085224 KICH 0.0036 high
ENSG00000085224 BRCA 0.025 high
ENSG00000085224 ESCA 0.006 high
ENSG00000085224 OV 0.043 low
ENSG00000085224 PRAD 0.03 high
ENSG00000085224 BLCA 0.039 low
ENSG00000085224 LIHC 0.0015 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency